The global connected drug packaging market size was valued at USD 4.86 billion in 2025 and is projected to grow from USD 5.27 billion in 2026 to USD 10.84 billion by 2034, registering a CAGR of 9.43% during the forecast period (2026–2034). North America dominated the connected drug packaging market with a market share of 39.84% in 2025.
Connected drug packaging integrates digital technologies such as RFID, NFC, QR codes, and sensors into pharmaceutical packaging to enable medication tracking, authentication, adherence monitoring, and patient engagement. It improves medication safety, supports regulatory compliance, reduces counterfeit risks, and is widely used for prescription drugs, biologics, and specialty therapies.
The connected drug packaging market demand is driven by the growing adoption of digital health technologies, rising need for medication adherence, and increasing concerns regarding counterfeit pharmaceuticals. Advances in smart packaging technologies, expanding pharmaceutical serialization requirements, and increasing use of connected healthcare platforms are also contributing to connected drug packaging market growth.
Download a Free Sample To learn more about this report,
The connected drug packaging market is sensitive to supply chain disruptions due to its reliance on electronic components, RFID and NFC tags, sensors, semiconductor chips, and specialized pharmaceutical packaging materials sourced through global supply networks. Disruptions in component availability, raw material procurement, and international logistics have affected production schedules, delayed product launches, and increased manufacturing costs for pharmaceutical packaging companies worldwide. The market is experiencing a K-shaped recovery, with technologically advanced companies and premium connected packaging solutions recovering faster than conventional packaging providers and smaller market participants.
Growing Adoption of Connected Drug Packaging for Better Medication Adherence
The need to improve medication adherence is driving the adoption of connected drug packaging across healthcare systems. Smart blister packs, connected pill bottles, and digital labels now provide reminders and record medication usage, helping patients follow prescribed treatments. This transition supports better treatment outcomes while reducing missed doses and hospital readmissions.
Increasing Use of NFC and Smart Sensor-enabled Drug Packaging
The focus on product authentication and supply chain transparency is accelerating the use of NFC and smart sensor-enabled drug packaging. Pharmaceutical companies are integrating these technologies into packaging to verify product authenticity, monitor handling conditions, and provide digital product information through smartphones. This transition improves patient safety and strengthens regulatory compliance across the pharmaceutical supply chain.
The connected drug packaging market forecasts continued investment activity driven by the growing adoption of digital healthcare solutions, rising demand for medication adherence technologies, and stricter pharmaceutical traceability requirements.
Key Investment and Funding Activities in Connected Drug Packaging Market, 2025–2026
Wiliot
USD 75 Million
In April 2026, the company received a strategic investment to accelerate the deployment of physical AI and battery-free IoT tags integrated into pharmaceutical packaging for item-level supply chain traceability.
SFO Technologies
USD 82 Million
In March 2026, SFO Technologies secured private equity funding of USD 82 million (INR 7.5 billion) to expand global manufacturing capacity for complex hardware, IoT, and RFID components powering connected healthcare and smart packaging solutions.
Controlant
USD 3 Million
In January 2025, the company closed an equity tranche as part of a broader financing round to advance its real-time monitoring solutions and software tracking applications for pharmaceutical and cold-chain packaging supply chains.
Growing Use of Self-administration of Prescription Drugs and Specialty Drug Therapies Drives Market
The growing use of self administration for prescription drugs is driving demand for connected drug packaging solutions. In 2026, the US Food and Drug Administration (FDA) continued to approve new medicines and biologics intended for patient self-administration through CDER, supporting the shift toward home based treatment. This encourages pharmaceutical companies to develop packaging with dosing reminders and treatment tracking features. As a result, demand for connected drug packaging continues to strengthen.
The increasing use of specialty drug therapies is creating demand for connected drug packaging. These therapies require strict dosing schedules, temperature monitoring, and continuous patient engagement throughout treatment. Connected packaging improves medication traceability and treatment compliance for complex therapies.
High Implementation Costs and Cybersecurity Concerns Restrains Market Expansion
The high cost of smart sensors, connectivity modules, and software integration limits the adoption of connected drug packaging. Pharmaceutical companies and packaging manufacturers must make significant investments in digital infrastructure and production upgrades. This slows adoption, particularly among small and mid-sized manufacturers.
Connected drug packaging collects and transmits patient medication data, creating concerns about data privacy and cybersecurity. Companies must comply with strict healthcare data protection regulations and invest in secure digital platforms. This increases implementation complexity and slows adoption across healthcare systems.
Increasing Number of Hybrid Clinical Trials and Expansion of Temperature Sensitive Biopharmaceuticals Offers Growth Opportunities to Market Players
The growing number of decentralized and hybrid clinical trials creates opportunities for connected drug packaging providers. Pharmaceutical companies and contract research organizations can use connected packaging to monitor medication use and improve protocol compliance among trial participants. This creates new opportunities for packaging manufacturers to develop digital trial support solutions.
The growing use of temperature sensitive biologics and specialty medicines creates opportunities for connected drug packaging providers. Pharmaceutical manufacturers and cold chain logistics companies require packaging that monitors storage conditions throughout distribution and patient use. This creates opportunities to develop connected packaging with real time temperature monitoring and alerts. Companies such as Schreiner MediPharm and Aptar Digital are developing connected solutions for temperature sensitive pharmaceuticals.
Limited Healthcare System Integration and Battery Performance of Connected Components Challenges Growth
Many healthcare providers continue to use legacy electronic health record and pharmacy management systems that are not fully compatible with connected drug packaging platforms. This limits seamless data exchange and reduces the clinical value of connected packaging solutions. As a result, healthcare organizations delay large scale implementation, slowing overall market growth.
The limited operating life of batteries and electronic components remains a challenge for connected drug packaging, especially for medicines with long shelf lives. Frequent maintenance or component replacement increases operational complexity and affects product reliability. For example, smart pill bottles with depleted batteries may fail to transmit adherence data or medication reminders, reducing confidence among healthcare providers and patients.
The NFC segment accounted for a share of 32.48% in 2025 due to increasing demand for product authentication, patient engagement, and digital access to medication information through smartphones. Easy integration into pharmaceutical packaging, support for real-time data sharing, and compatibility with mobile health applications continue to strengthen demand for NFC-enabled packaging solutions.
The smart sensors segment is expected to grow at a CAGR of around 10.12% during the forecast period due to rising demand for real time monitoring of medication usage, storage conditions, and treatment compliance. Advancements in sensor miniaturization and increasing deployment in high-value pharmaceuticals continue to support market growth.
Request Customizationto receive a tailored report.
The smart blister packs segment accounted for a share of 41.36% in the connected drug packaging market in 2025 due to their ability to monitor medication adherence, provide dose reminders, and record dosing events for patients with chronic diseases. Their widespread use in oral solid dosage forms and compatibility with digital health platforms continue to strengthen demand.
The smart bottles segment is expected to grow at a CAGR of 9.73% during the forecast period, driven by increasing use in chronic disease management, expansion of home healthcare, and growing demand for connected medication monitoring solutions. Features such as reminder alerts and real-time adherence tracking are supporting segment growth.
The pharmaceutical companies segment accounted for a share of 47.58% in 2025 due to increasing investment in patient centric drug delivery, product differentiation, and digital health solutions. Connected packaging enables manufacturers to improve medication adherence, collect treatment data, and enhance patient engagement throughout the therapy lifecycle.
The contract packaging organizations segment is expected to grow at a CAGR of 9.56% during the forecast period, driven by increasing outsourcing of pharmaceutical packaging operations and growing demand for specialized connected packaging technologies. Investments in smart packaging capabilities and digital manufacturing infrastructure continue to support segment growth.
The Bluetooth-enabled segment accounted for a share of 48.27% in 2025 due to low power consumption, reliable short-range communication, and compatibility with smartphones and digital health applications. It enables real-time medication reminders and adherence monitoring, supporting wider use across connected drug packaging solutions.
The cellular-enabled segment is expected to grow at a CAGR of 10.41% during the forecast period, driven by increasing demand for remote patient monitoring and real time data transmission without smartphone dependency.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by Advanced Digital Healthcare Infrastructure and Strong Pharmaceutical Innovation
The North America connected drug packaging market accounted for the largest regional share of 39.84% in 2025, driven by widespread adoption of digital healthcare technologies, strong pharmaceutical innovation, and increasing demand for medication adherence solutions. The region also benefits from advanced healthcare infrastructure, established pharmacy networks, and high investment in connected health technologies.
The US connected drug packaging market was valued at USD 0.31 billion in 2025, driven by increasing use of digital therapeutics, expansion of remote patient monitoring, and growing demand for medication adherence solutions. Pharmaceutical companies and healthcare providers are investing in connected packaging to improve treatment compliance and patient engagement. According to the American Hospital Association, the US had more than 6,000 hospitals in 2025, supporting the integration of connected medication management solutions across healthcare systems.
The Canada connected drug packaging market was valued at USD 0.05 billion in 2025, supported by increasing adoption of digital pharmacy services, growing chronic disease management programs, and rising focus on medication safety. The Canadian Medication Incident Reporting and Prevention System (CMIRPS) continues to promote medication safety by collecting and analyzing medication incident data, encouraging wider adoption of connected packaging technologies that improve adherence and reduce dispensing errors.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Driven by Digital Healthcare Expansion and Growing Pharmaceutical Manufacturing
The Asia Pacific connected drug packaging market is expected to grow at a CAGR of 10.28% during the forecast period, showcasing the fastest regional growth. Growth is supported by expanding pharmaceutical manufacturing, increasing digital healthcare initiatives, and rising adoption of connected health technologies. Governments and pharmaceutical companies are investing in smart healthcare infrastructure and digital medication management systems.
The China connected drug packaging market was valued at USD 0.09 billion in 2025, supported by rapid pharmaceutical manufacturing growth, expansion of digital healthcare platforms, and increasing investment in smart medical technologies. China's National Healthcare Security Administration (NHSA) has expanded electronic prescription and internet hospital services, accelerating the adoption of digital healthcare platforms that support connected medication management.
The India connected drug packaging market was valued at USD 0.04 billion in 2025, fueled by expanding pharmaceutical production and increasing demand for medication adherence solutions. India is home to more than 3,000 pharmaceutical companies and over 10,500 manufacturing facilities, supporting demand for connected drug packaging solutions across large-scale pharmaceutical production and distribution.
The Japan connected drug packaging market was valued at USD 0.06 billion in 2025, supported by the country's aging population, advanced healthcare infrastructure, and strong emphasis on medication safety. According to Japan's Ministry of Health, Labour and Welfare, more than 75,000 community pharmacies were operating across Japan in 2025, supporting wider deployment of connected medication services.
The connected drug packaging market competitive landscape is moderately fragmented, with competition centered among pharmaceutical packaging companies, digital health technology providers, and smart packaging solution developers. Leading players compete through advancements in connected packaging technologies, sensor integration, cloud based monitoring platforms, and compatibility with digital health ecosystems. Emerging players focus on developing patient centric packaging solutions, expanding software capabilities, and strengthening partnerships with pharmaceutical manufacturers and healthcare providers. The connected drug packaging market ecosystem is shaped by increasing demand for medication adherence solutions, growth in digital healthcare, evolving pharmaceutical packaging standards, and the need for secure, connected technologies that improve patient engagement, treatment monitoring, and medication traceability.
May 2026: Schreiner MediPharm and HERMA showcased an integrated RFID labeling solution for pharmaceutical vials at interpack 2026.
February 2026: Schreiner MediPharm and OECHSLER Health launched Cap-Lock for Vials, integrating RFID and NFC technologies.
October 2025: Aptar Digital Health received US FDA 510(k) clearance for HeroTracker Sense, a connected add on for pressurized Metered Dose Inhalers (pMDIs) that monitors inhaler usage and technique to support respiratory disease management and medication adherence.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Analyst
Pavan Warade is a Research Analyst with over 4 years of expertise in Technology and Aerospace & Defense markets. He delivers detailed market assessments, technology adoption studies, and strategic forecasts. Pavan’s work enables stakeholders to capitalize on innovation and stay competitive in high-tech and defense-related industries.
Sensor-based Packaging Market Size, Share, Growth, 2034
Time Temperature Indicator Market Size, Share, Growth, 2034
Connected Packaging Market Size, Share, Growth, 2034
RFID Packaging Market Size, Share, Growth, 2034
Interactive Packaging Market Size, Share, Growth, 2034
Digital Traceability Packaging Market Size, Share, 2034
We are featured on:
sales@straitsresearch.com